IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 53 filers reported holding IKENA ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,443,445 | -32.2% | 2,180,934 | +2.8% | 3.74% | -11.4% |
| Q2 2023 | $13,920,582 | +142.9% | 2,122,040 | +27.8% | 4.22% | +177.7% |
| Q1 2023 | $5,730,010 | +31.6% | 1,660,872 | +1.4% | 1.52% | +31.1% |
| Q4 2022 | $4,355,409 | +1.0% | 1,637,372 | +34.8% | 1.16% | +0.1% |
| Q3 2022 | $4,311,000 | -10.8% | 1,214,304 | +11.3% | 1.16% | -37.2% |
| Q2 2022 | $4,833,000 | -2.8% | 1,090,937 | +33.9% | 1.85% | -12.6% |
| Q1 2022 | $4,970,000 | -51.4% | 814,755 | -0.0% | 2.11% | -37.7% |
| Q4 2021 | $10,217,000 | +157.0% | 814,756 | +158.7% | 3.39% | +192.3% |
| Q3 2021 | $3,975,000 | -65.3% | 315,000 | -61.3% | 1.16% | -56.4% |
| Q2 2021 | $11,440,000 | -50.3% | 814,756 | 0.0% | 2.66% | -42.3% |
| Q1 2021 | $23,017,000 | – | 814,756 | – | 4.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,249,123 | $9,738,703 | 8.94% |
| CHI Advisors LLC | 2,180,934 | $9,443,445 | 3.74% |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $21,728,711 | 3.36% |
| ACUTA CAPITAL PARTNERS, LLC | 551,010 | $2,385,873 | 1.60% |
| Vida Ventures Advisors, LLC | 225,192 | $975,081 | 1.51% |
| BVF INC/IL | 3,169,164 | $13,722,480 | 0.37% |
| Artal Group S.A. | 1,849,513 | $8,008 | 0.34% |
| Orbimed Advisors | 3,186,166 | $13,796,099 | 0.29% |
| OUP Management Co., LLC | 26,833 | $116,187 | 0.26% |
| Avoro Capital Advisors LLC | 1,640,000 | $7,101,200 | 0.11% |